TW200503798A - Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy - Google Patents
Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapyInfo
- Publication number
- TW200503798A TW200503798A TW093112112A TW93112112A TW200503798A TW 200503798 A TW200503798 A TW 200503798A TW 093112112 A TW093112112 A TW 093112112A TW 93112112 A TW93112112 A TW 93112112A TW 200503798 A TW200503798 A TW 200503798A
- Authority
- TW
- Taiwan
- Prior art keywords
- arsenic
- tumor
- cancer
- conjunction
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 229910052785 arsenic Inorganic materials 0.000 title abstract 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000001959 radiotherapy Methods 0.000 title abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW093112112A TW200503798A (en) | 2004-04-30 | 2004-04-30 | Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW093112112A TW200503798A (en) | 2004-04-30 | 2004-04-30 | Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200503798A true TW200503798A (en) | 2005-02-01 |
TWI335229B TWI335229B (enrdf_load_stackoverflow) | 2011-01-01 |
Family
ID=45075010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093112112A TW200503798A (en) | 2004-04-30 | 2004-04-30 | Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW200503798A (enrdf_load_stackoverflow) |
-
2004
- 2004-04-30 TW TW093112112A patent/TW200503798A/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI335229B (enrdf_load_stackoverflow) | 2011-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2471588A (en) | Therapeutic peptidomimetic macrocycles | |
IL184617A0 (en) | Dr5 antibodies and uses thereof | |
MX339142B (es) | Combinaciones y metodos de administracion de agentes terapeuticos y terapia de combinacion. | |
MX2009006779A (es) | Antagonistas especificos para terapia con adyuvantes y neo-adyuvantes y el tratamiento de tumores en etapa temprana. | |
SG10201811480WA (en) | Therapeutic compounds and compositions | |
MX394667B (es) | El uso de 1-(4-ciano-3-trifluorometil-fenil)-3-[7-(4- ciano-3-trifluorometll-fen|l)-6-tioxo-5-p-tolilo-5,7-diazaespiro[3.4]oct-8-ilideno]-tiourea. | |
IL164599A0 (en) | Combination therapy for the treatment of cancer | |
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
IL307964A (en) | Combined treatment for cancer | |
MX2007003505A (es) | Combinacion que comprende zd6474 e imatinib. | |
TN2009000490A1 (en) | Cancer treatment combination therapy comprising vinflunine and trastuzumab | |
IL191797A0 (en) | Combination of azd2171 and pemetrexed | |
IL164564A0 (en) | Combination therapy for the treatment of cancer | |
WO2011056566A3 (en) | Compounds and methods for treatment of cancer | |
ZA200709542B (en) | Combination therapy in the treatment of cancer | |
TW200633700A (en) | Methods of using temozolomide formulation intrathecally in the treatment of cancers | |
WO2010065563A3 (en) | Apratoxin therapeutic agents: mechanism and methods of treatment | |
WO2008098183A3 (en) | Combination therapy for treating cancer | |
MX2020013883A (es) | Tratamientos oncológicos con agentes de zinc. | |
BRPI0806257A2 (pt) | método de tratamento, e, uso de uma composição imunoterapêutica | |
GB0316127D0 (en) | Combination therapy | |
TW200503798A (en) | Arsenic-containing pharmaceutical composition for treatment of tumor/cancer in conjunction with radiation therapy | |
WO2006060819A3 (en) | Dhmeq as a sensitizing agent for chemotherapy and immunotherapy of resistant cancer cells | |
IL164356A (en) | Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |